PIK3CA and non-small cell lung carcinoma: Our study showed that PIK3CA expression status was not an independent risk factor for OS of NSCLC patients (HR = 0.80; 95% CI: 0.58-1.12; P = 0.193), which is consistent with the results of 3 included studies [16, 19, 20].